NerveTrend vs. NerveAssure in Prevention of Recurrent Laryngeal Nerve Injury During Thyroid Surgery
Launched by MARCIN BARCZYNSKI · Feb 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different techniques, called NerveTrend and NerveAssure, to help prevent injuries to the recurrent laryngeal nerve (RLN) during thyroid surgery. The recurrent laryngeal nerve is important for voice function, and the trial aims to see if the NerveTrend technique is just as good as the NerveAssure technique in identifying potential nerve injuries during surgery. The researchers believe that NerveTrend might be a useful option, especially in places where resources are limited.
To participate in this trial, individuals must be planning to have their first bilateral (both sides) thyroid surgery. Unfortunately, those with previous thyroid surgeries, those who are pregnant or breastfeeding, or those under 18 or over 75 years old cannot join. If eligible, participants will be monitored during their surgery, and the main goal is to check for any nerve injuries the day after the surgery using a procedure called direct laryngoscopy. Overall, this study could provide valuable insights into safer surgical techniques for thyroid conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • planned, first-time, bilateral thyroid surgery
- Exclusion Criteria:
- • planned unilateral thyroid surgery,
- • previous thyroid surgery,
- • pregnancy
- • lactation
- • age \< 18 years
- • age \> 75 years
- • ASA 4-5 grade (American Society of Anesthesiology)
- • inability to comply with the follow-up protocol
About Marcin Barczynski
Marcin Barczyński is a distinguished clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, he focuses on innovative trial designs that enhance the efficiency and efficacy of clinical studies. His leadership emphasizes rigorous adherence to regulatory standards and ethical practices, ensuring the integrity of data collection and participant safety. Barczyński's collaborative approach fosters partnerships with research institutions and healthcare providers, driving forward the development of groundbreaking therapies and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Krakow, , Poland
Patients applied
Trial Officials
Marcin Barczynski, MD, PhD
Principal Investigator
Department of Endocrine Surgery, Jagiellonian University College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported